Top Markets
Coin of the day
Vaxcell-Bio Therapeutics Co., Ltd. Vaxcell-Bio Therapeutics Co., Ltd.

Vaxcell-Bio Therapeutics Co., Ltd.

323990
Rank in Stocks #24157
Established in 2010, Vaxcell-Bio Therapeutics Co., Ltd. specializes in the... Established in 2010, Vaxcell-Bio Therapeutics Co., Ltd. specializes in the research, development, and commercialization of immune cell-based therapies designed to treat cancer, primarily operating within South Korea. The company's main base of operations is located in Hwasun-eup, South Korea.
Share Price
$2.77
Last synced: 2026-08-21
Market Cap
$64.26M
Change (1 day)
-4.64%
Change (1 year)
-57.45%
Country
KR
Trade Vaxcell-Bio Therapeutics Co., Ltd. (323990)

Category

P/B ratio for Vaxcell-Bio Therapeutics Co., Ltd. (323990)
P/B ratio as of 2026 TTM: 0
According to Vaxcell-Bio Therapeutics Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Vaxcell-Bio Therapeutics Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH